Macrophage activation of the TREM2-DAP12-SYK pathway shapes the adipose tissue microenvironment in obesity and unveils the therapeutic potential of natural compounds egcg and SMRR. This evidence concerns the gene TYROBP and obesity due to melanocortin 4 receptor deficiency.